Airway Management Devices Market (Product Type: Supraglottic Device, Infraglottic Device, Resuscitators, and Laryngoscope; Patient Age: Adult and Pediatric) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Airway Management Devices Market (Product Type: Supraglottic Device, Infraglottic Device, Resuscitators, and Laryngoscope; Patient Age: Adult and Pediatric) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Companies Mentioned

Evonik Industries AG
Huntsman International LLC.
INEOS Group Holdings S.A.
Solutia Inc.
Arkema S.A.
Celanese Corporation
Bayer AG
DIC Corporation
DowDuPont Inc
Royal DSM N.V.
LANXESS
BASF SE.
Allnex Holdings S.à r.l.

Countries

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Forecast Year (first) - 2022

Forecast Year (last) - 2031

Forecast Year ( first)  Value - 1.1

Forecast Year (last) Value - 2.3

CAGR % - 0.077

Currency - US$ Bn


1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Airway Management Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Airway Management Devices Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Increase in prevalence of respiratory diseases
5.2. Technological advancements
5.3. Key Industry Events
5.4. COVID-19 Impact
6. Global Airway Management Devices Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product Type, 2017–2031
6.3.1. Supraglottic Device
6.3.2. Infraglottic Device
6.3.3. Resuscitators
6.3.4. Laryngoscope
6.4. Market Attractiveness Analysis, by Product Type
7. Global Airway Management Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Operating Room (OR)
7.3.2. Intensive Care Unit (ICU)
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Airway Management Devices Market Analysis and Forecast, by Patient Age
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Patient Age, 2017–2031
8.3.1. Adult
8.3.2. Pediatric
8.4. Market Attractiveness Analysis, by Patient Age
9. Global Airway Management Devices Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Airway Management Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product Type, 2017–2031
10.2.1. Supraglottic Device
10.2.2. Infraglottic Device
10.2.3. Resuscitators
10.2.4. Laryngoscope
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Operating Room (OR)
10.3.2. Intensive Care Unit (ICU)
10.3.3. Others
10.4. Market Value Forecast, by Patient Age, 2017–2031
10.4.1. Adult
10.4.2. Pediatric
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. by Product Type
10.6.2. by End-user
10.6.3. by Patient Age
10.6.4. by Country
11. Europe Airway Management Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2017–2031
11.2.1. Supraglottic Device
11.2.2. Infraglottic Device
11.2.3. Resuscitators
11.2.4. Laryngoscope
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Operating Room (OR)
11.3.2. Intensive Care Unit (ICU)
11.3.3. Others
11.4. Market Value Forecast, by Patient Age, 2017–2031
11.4.1. Adult
11.4.2. Pediatric
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. by Product Type
11.6.2. by End-user
11.6.3. by Patient Age
11.6.4. by Country/Sub-region
12. Asia Pacific Airway Management Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2017–2031
12.2.1. Supraglottic Device
12.2.2. Infraglottic Device
12.2.3. Resuscitators
12.2.4. Laryngoscope
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Operating Room (OR)
12.3.2. Intensive Care Unit (ICU)
12.3.3. Others
12.4. Market Value Forecast, by Patient Age, 2017–2031
12.4.1. Adult
12.4.2. Pediatric
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. by Product Type
12.6.2. by End-user
12.6.3. by Patient Age
12.6.4. by Country/Sub-region
13. Latin America Airway Management Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2017–2031
13.2.1. Supraglottic Device
13.2.2. Infraglottic Device
13.2.3. Resuscitators
13.2.4. Laryngoscope
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Operating Room (OR)
13.3.2. Intensive Care Unit ICU
13.3.3. Others
13.4. Market Value Forecast, by Patient Age, 2017–2031
13.4.1. Adult
13.4.2. Pediatric
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. by Product Type
13.6.2. by End-user
13.6.3. by Patient Age
13.6.4. by Country/Sub-region
14. Middle East & Africa Airway Management Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2017–2031
14.2.1. Supraglottic Device
14.2.2. Infraglottic Device
14.2.3. Resuscitators
14.2.4. Laryngoscope
14.3. Market Value Forecast, by End-user, 2017–2031
14.3.1. Operating Room(OR)
14.3.2. Intensive Care Unit (ICU)
14.3.3. Others
14.4. Market Value Forecast, by Patient Age, 2017–2031
14.4.1. Adult
14.4.2. Pediatric
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. by Product Type
14.6.2. by End-user
14.6.3. by Patient Age
14.6.4. by Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2021
15.3. Company Profiles
15.3.1. Ambu A/S
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. GE Healthcare
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Karl Storz GmbH & Co. KG
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Koninklijke Philips N.V.
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Medtronic plc
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Medline Industries, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Olympus Corporation
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Smiths Medical
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Teleflex Incorporated
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. VYAIRE
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings